Skip to main content
Clinical Trials/NCT06614218
NCT06614218
Not yet recruiting
Not Applicable

Minimally Invasive Micro Sclerostomy (MIMS®) Retrospective Chart Review

Sanoculis Ltd1 site in 1 country40 target enrollmentStarted: February 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
40
Locations
1
Primary Endpoint
Change in IOP from medicated baseline at 12 months post-MIMS® surgery

Overview

Brief Summary

This is a post-market clinical follow-up, retrospective chart review of MIMS® surgical procedures conducted during time period between Sep 2023 and May 2025.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
40 Years to 85 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Eye treated with MIMS® Device as a standalone procedure
  • MIMS® surgery was performed between 27 Sep 2023 and 30 April 2024

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in IOP from medicated baseline at 12 months post-MIMS® surgery

Time Frame: Medicated baseline at 12 months post-MIMS® surgery

Change in the number of topical IOP-lowering medications from medicated baseline at 12 months post-MIMS® surgery

Time Frame: Medicated baseline at 12 months post-MIMS® surgery

Success rate at 12 months post-MIMS® surgery

Time Frame: 12 months post-MIMS® surgery

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials